Program Topic

"Once-Weekly Mounjaro: A New Class. A Different Perspective on T2D Treatment” Mounjaro – the first and ONLY approved single molecule that activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-!) receptors in the body

February 15th, 2024 (THURSDAY)
6:30 pm Social – 7:00 pm Program Presentation
Hudson and Essex – 51 East Fourth Street – Mansfield, OH 44902
Eli Lilly - Frank Felice – Executive Diabetes Sales Specialist


Samuel Ray Anderson, MD, BS Pharm, FACE

Dr. Samuel R. Anderson is an endocrinologist in Columbus, Ohio and is affiliated with OhioHealth Riverside Methodist Hospital. He received his medical degree from University of Cincinnati College of Medicine and has been in practice for more than 20 years. Dr. Samuel R. Anderson has expertise in treating Chronic diabetes, Obesity, among other conditions


Endocrinology, Diabetes & Metabolism

Endocrinologists treat hormone-related conditions, which most commonly include diabetes, thyroid disease, pituitary gland issues and hormonal imbalances



     Lipid Metabolism

RSVP Deadline
Monday, February 12, 2024

In adherence with the PhRMA Code on Interactions with Healthcare Professionals, attendance at this educational program is limited to healthcare professionals. Accordingly, attendance by guests or spouses is not appropriate. Your support of these ethical guidelines will help to ensure a high quality, learning environment for all participating Healthcare Professionals. Thank You.